Sarepta Therapeutics Inc. (S1RP34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
3. 87
-0.02
-0.5141%
R$
9.82B Market Cap
- P/E Ratio
- Div Yield
4 Volume
-6.99 Eps
R$ 3.89
Previous Close Want to track S1RP34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sarepta Therapeutics Inc. (S1RP34) Statistics
Valuation metrics
Market Cap 9.82B
Enterprise value 4.57B
Trailing P/E (ttm) 51.67
Forward P/E -
PEG ratio -0.15
Price/Sales (ttm) 4.5
Price/Book (mrq) 0.07
Enterprise Value/Revenue 0.43
Enterprise Value/EBITDA 20.19
Overview
Shares outstanding 104.96M
Float 93.47M
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 1.17K
Average volume (90 days) 1.35K
Price summary
52-Week low 2.88
52-Week high 10.43
Beta 0.26
50-Day moving average 5.04
200-Day moving average 5.28
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.03%
Operating margin 0.49%
Operational effectiveness
Return on assets 0%
Return on equity 0.05%
Income Statement
Revenue (ttm) 10.71B
Revenue per share (ttm) 21.41
Quarterly revenue growth (yoy) -0.02%
Gross profit (ttm) -694.37M
EBITDA 226.39M
Net income to common (ttm) 318.91M
Diluted EPS (ttm) 0.09
Quarterly earnings growth (yoy) -0.33%
Balance Sheet
Total cash (mrq) 3.2B
Total cash per share (mrq) 6.19
Total debt (mrq) 5.13B
Total Debt/Equity (mrq) 69.57
Current ratio (mrq) 4.63%
Book value per share (mrq) 69.99
Cash Flow
Cash flow statement 859.19M
Levered free cash flow (LFCF) 1B
